28 April 2026
EU-wide marketing authorization for veroblue-3 vaccine and strategic out-licensing agreement
- First EU-wide Marketing Authorization (MA) for Verovaccines
- First-in-class recombinant BTV-vaccine
- First DIVA-enabled BTV-vaccine
- First out-licencing agreement for us